in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—17 September 2013
3:49 AM MDT | September 17, 2013 | Deepti Ramesh
ICIG to acquire peptide APIs firm Peptisyntha from Solvay International Chemical Investors Group (ICIG), a privately owned industrial holding company, says that it has entered into an agreement with Solvay to acquire the latter's subsidiary Peptisyntha (Brussels), a custom manufacturer of peptides for pharmaceutical use. Financial details of the deal have not been disclosed. The transaction is expected to be completed this fall, and Peptisyntha will become a member of ICIG's CordenPharma platform as its third site offering peptides manufacturing. For Solvay, the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee